U.K. Geriatrician: Statins, Antihypertensives "Greatly" Overprescribed for Adults 80 and Older
"The data strongly suggest that we are over-treating many healthy patients aged 80+ regarding stroke prevention," concludes U.K. geriatrician Kit Byatt in a perspective published in Evidence-Based Medicine.
Byatt offers a brief review of the evidence, noting that the large HYVET study in China and Europe showed only modest stroke-prevention benefits with antihypertensive therapy in those aged 80 and older. Similarly, the PROSPER trial, a large study of pravastatin in patients aged 70 to 82 in Europe, failed to find a significant stroke-prevention benefit with treatment. Byatt also notes that morbidity associated with statins may be underestimated. Journal Watch
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment